Literature DB >> 21321278

Beta-cell imaging: opportunities and limitations.

Thomas C Kwee, Sandip Basu, Babak Saboury, Drew A Torigian, Ali Naji, Abass Alavi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21321278      PMCID： PMC3401272          DOI： 10.2967/jnumed.110.085530

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  8 in total

1.  An autoradiographic study of [(18)F]FDG uptake to islets of Langerhans in NOD mouse.

Authors:  Teemu Kalliokoski; Olli Simell; Merja Haaparanta; Tapio Viljanen; Olof Solin; Juhani Knuuti; Pirjo Nuutila
Journal:  Diabetes Res Clin Pract       Date:  2005-06-13       Impact factor: 5.602

2.  Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET.

Authors:  Marc Hickeson; Mijin Yun; Alexander Matthies; Hongming Zhuang; Lars-Eric Adam; Lester Lacorte; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-10-02       Impact factor: 9.236

Review 3.  Imaging of beta-cell mass and function.

Authors:  Masanori Ichise; Paul E Harris
Journal:  J Nucl Med       Date:  2010-06-16       Impact factor: 10.057

4.  In vitro and in vivo evaluation of novel glibenclamide derivatives as imaging agents for the non-invasive assessment of the pancreatic islet cell mass in animals and humans.

Authors:  S Schneider; P J Feilen; M Schreckenberger; M Schwanstecher; C Schwanstecher; H G Buchholz; O Thews; K Oberholzer; A Korobeynikov; A Bauman; S Comagic; M Piel; E Schirrmacher; C Y Shiue; A A Alavi; P Bartenstein; F Rösch; M M Weber; H H Klein; R Schirrmacher
Journal:  Exp Clin Endocrinol Diabetes       Date:  2005-07       Impact factor: 2.949

5.  Non-invasive imaging of beta cell mass: a quantitative analysis.

Authors:  Ian R Sweet; Daniel L Cook; Ake Lernmark; Carla J Greenbaum; Kenneth A Krohn
Journal:  Diabetes Technol Ther       Date:  2004-10       Impact factor: 6.118

6.  Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.

Authors:  Olga T Hardy; Miguel Hernandez-Pampaloni; Janet R Saffer; Joshua S Scheuermann; Linda M Ernst; Richard Freifelder; Hongming Zhuang; Courtney MacMullen; Susan Becker; N Scott Adzick; Chaitanya Divgi; Abass Alavi; Charles A Stanley
Journal:  J Clin Endocrinol Metab       Date:  2007-09-25       Impact factor: 5.958

7.  Diabetes mellitus in pancreatic cancer: is it a causal relationship?

Authors:  Iki Katsumichi; Parviz M Pour
Journal:  Am J Surg       Date:  2007-10       Impact factor: 2.565

Review 8.  Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased states.

Authors:  Sandip Basu; Habib Zaidi; Mohamed Houseni; Gonca Bural; Jay Udupa; Paul Acton; Drew A Torigian; Abass Alavi
Journal:  Semin Nucl Med       Date:  2007-05       Impact factor: 4.446
  8 in total
  8 in total

Review 1.  Molecular imaging of β-cells: diabetes and beyond.

Authors:  Weijun Wei; Emily B Ehlerding; Xiaoli Lan; Quan-Yong Luo; Weibo Cai
Journal:  Adv Drug Deliv Rev       Date:  2018-07-03       Impact factor: 15.470

Review 2.  Futility of attempts to detect and quantify beta cells by PET imaging in the pancreas: why it is time to abandon the approach.

Authors:  Abass Alavi; Thomas J Werner
Journal:  Diabetologia       Date:  2018-06-29       Impact factor: 10.122

3.  β-Cell mass imaging with DTBZ positron emission tomography: is it possible?

Authors:  Björn A Blomberg; Olof Eriksson; Babak Saboury; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2013-02       Impact factor: 3.488

Review 4.  Beta-cell imaging: call for evidence-based and scientific approach.

Authors:  Björn A Blomberg; Ion Codreanu; Gang Cheng; Thomas J Werner; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2013-04       Impact factor: 3.488

5.  PET quantification of pancreatic VMAT 2 binding using (+) and (-) enantiomers of [¹⁸F]FP-DTBZ in baboons.

Authors:  Paul E Harris; Michael D Farwell; Masanori Ichise
Journal:  Nucl Med Biol       Date:  2012-10-26       Impact factor: 2.408

6.  In vivo imaging of endogenous pancreatic β-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetrabenazine and PET.

Authors:  Marc D Normandin; Kitt F Petersen; Yu-Shin Ding; Shu-Fei Lin; Sarita Naik; Krista Fowles; Daniel M Skovronsky; Kevan C Herold; Timothy J McCarthy; Roberto A Calle; Richard E Carson; Judith L Treadway; Gary W Cline
Journal:  J Nucl Med       Date:  2012-05-09       Impact factor: 10.057

7.  Vesicular monoamine transporter, type 2 (VMAT2) expression as it compares to insulin and pancreatic polypeptide in the head, body and tail of the human pancreas.

Authors:  Matthew Freeby; Masanori Ichise; Paul E Harris
Journal:  Islets       Date:  2012-11-01       Impact factor: 2.694

8.  Clinical and scientific value in the pursuit of quantification of beta cells in the pancreas by PET imaging.

Authors:  Gary W Cline; Timothy J McCarthy; Richard E Carson; Roberto A Calle
Journal:  Diabetologia       Date:  2018-08-22       Impact factor: 10.460
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.